chr16-28898456-GC-G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_004320.6(ATP2A1):​c.1764+6delC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0184 in 1,612,294 control chromosomes in the GnomAD database, including 1,955 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.064 ( 849 hom., cov: 31)
Exomes 𝑓: 0.014 ( 1106 hom. )

Consequence

ATP2A1
NM_004320.6 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.108

Publications

4 publications found
Variant links:
Genes affected
ATP2A1 (HGNC:811): (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1) This gene encodes one of the SERCA Ca(2+)-ATPases, which are intracellular pumps located in the sarcoplasmic or endoplasmic reticula of muscle cells. This enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen, and is involved in muscular excitation and contraction. Mutations in this gene cause some autosomal recessive forms of Brody disease, characterized by increasing impairment of muscular relaxation during exercise. Alternative splicing results in three transcript variants encoding different isoforms. [provided by RefSeq, Oct 2013]
ATP2A1 Gene-Disease associations (from GenCC):
  • Brody myopathy
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 16-28898456-GC-G is Benign according to our data. Variant chr16-28898456-GC-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 96541.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.186 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP2A1NM_004320.6 linkc.1764+6delC splice_region_variant, intron_variant Intron 14 of 22 ENST00000395503.9 NP_004311.1 O14983-2Q7Z675
ATP2A1NM_173201.5 linkc.1764+6delC splice_region_variant, intron_variant Intron 14 of 21 NP_775293.1 O14983-1Q7Z675
ATP2A1NM_001286075.2 linkc.1389+6delC splice_region_variant, intron_variant Intron 12 of 20 NP_001273004.1 O14983-3Q7Z675

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP2A1ENST00000395503.9 linkc.1764+6delC splice_region_variant, intron_variant Intron 14 of 22 1 NM_004320.6 ENSP00000378879.5 O14983-2
ATP2A1ENST00000357084.7 linkc.1764+6delC splice_region_variant, intron_variant Intron 14 of 21 2 ENSP00000349595.3 O14983-1
ATP2A1ENST00000536376.5 linkc.1389+6delC splice_region_variant, intron_variant Intron 12 of 20 2 ENSP00000443101.1 O14983-3
ATP2A1ENST00000564732.1 linkn.*407+6delC splice_region_variant, intron_variant Intron 6 of 6 5 ENSP00000457357.1 H3BTW4

Frequencies

GnomAD3 genomes
AF:
0.0637
AC:
9692
AN:
152158
Hom.:
848
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.190
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0232
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.147
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.0170
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00614
Gnomad OTH
AF:
0.0425
GnomAD2 exomes
AF:
0.0312
AC:
7554
AN:
242494
AF XY:
0.0258
show subpopulations
Gnomad AFR exome
AF:
0.193
Gnomad AMR exome
AF:
0.0159
Gnomad ASJ exome
AF:
0.00780
Gnomad EAS exome
AF:
0.151
Gnomad FIN exome
AF:
0.0178
Gnomad NFE exome
AF:
0.00597
Gnomad OTH exome
AF:
0.0251
GnomAD4 exome
AF:
0.0137
AC:
19997
AN:
1460018
Hom.:
1106
Cov.:
31
AF XY:
0.0128
AC XY:
9302
AN XY:
726260
show subpopulations
African (AFR)
AF:
0.195
AC:
6520
AN:
33440
American (AMR)
AF:
0.0169
AC:
751
AN:
44436
Ashkenazi Jewish (ASJ)
AF:
0.00751
AC:
196
AN:
26094
East Asian (EAS)
AF:
0.116
AC:
4613
AN:
39622
South Asian (SAS)
AF:
0.00309
AC:
266
AN:
86128
European-Finnish (FIN)
AF:
0.0181
AC:
958
AN:
52956
Middle Eastern (MID)
AF:
0.0208
AC:
120
AN:
5756
European-Non Finnish (NFE)
AF:
0.00437
AC:
4856
AN:
1111314
Other (OTH)
AF:
0.0285
AC:
1717
AN:
60272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1035
2070
3105
4140
5175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
378
756
1134
1512
1890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0638
AC:
9711
AN:
152276
Hom.:
849
Cov.:
31
AF XY:
0.0622
AC XY:
4629
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.190
AC:
7881
AN:
41538
American (AMR)
AF:
0.0232
AC:
354
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3472
East Asian (EAS)
AF:
0.147
AC:
758
AN:
5160
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4830
European-Finnish (FIN)
AF:
0.0170
AC:
181
AN:
10630
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00613
AC:
417
AN:
68036
Other (OTH)
AF:
0.0426
AC:
90
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
410
820
1230
1640
2050
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00761
Hom.:
8
Bravo
AF:
0.0702
Asia WGS
AF:
0.0680
AC:
235
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Brody myopathy Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 15, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.11
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs66716803; hg19: chr16-28909777; COSMIC: COSV107451984; COSMIC: COSV107451984; API